eli lilly wegovy - Search News

News

Eli Lilly Stock Falls

Barron's on MSN · 15h

Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.

Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.

Eli Lilly stock sell-off was 'overrreaction': Analysts

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an overreaction to GLP-1 news.

Bloomberg · 9h

Stock Movers: Apple, Eli Lilly, Spotify

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Lilly, CVS Health and Zepbound

pharmaphorum · 9h

Lilly hit as PBM drops Zepbound, but retains Wegovy

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo Nordisk's newly forged alliances with three leading telehealth companies to drive self-pay sales of its weight loss drug.

Reuters on MSN · 1d

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum.

Associated Press News on MSN · 1d

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

15hon MSN

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Fierce Pharma1d

In major blow for Lilly, Novo strikes deal giving Wegovy preferred access on CVS Caremark formulary

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

1don MSN

Eli Lilly’s Shares Drop After Outlook Tempers Growth Story

Eli Lilly & Co.’s shares dropped in morning trading after CVS Health Corp. announced a plan to drop its blockbuster ...

GlobalData on MSN1d

Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

1don MSN

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

1d

Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

2d

Wegovy can treat a dangerous liver disease, study finds

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

3d

Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results